Curavac

CuraVac is an innovative young company founded to take a newly discovered technique for creating therapeutic vaccines against autoimmune diseases from discovery through to being available for the treatment of humans.

Typical autoimmune diseases that should be treatable by CuraVac vaccines include myasthenia gravis, multiple sclerosis, diabetes, rheumatoid arthritis and systemic lupus erythematosis.

The pioneering vaccine, already in development, is for the treatment of myasthenia gravis.

Through this web site, CuraVac aims to bring its activities to the attention of the wider public who want to know about CuraVac and its team and to offer an investment or donation opportunity to those who wish to support its work.

CuraVac is supported by The Myasthenia Gravis Garden State Chapter.